• Azza Sarfraz, Zouina Sarfraz, Mohammad Ashraf, and Huma Ashraf.
• Azza Sarfraz, Aga Khan University, Karachi, Pakistan.
• Pak J Med Sci. 2022 Mar 1; 38 (4Part-II): 105610631056-1063.

AbstractThe COVID-19 pandemic has highlighted the vulnerability of countries worldwide and their abilities to cope with the fast-paced demands of the research and medical community. A key to promoting ethical decision-making frameworks is by calibrating the sustainability at regional, national, and global levels to incorporate coordinated reforms. We performed a sustained ethical analysis and critically reviewed evidence addressing country-level responses to practices during the COVID-19 pandemic using PubMed (MEDLINE), Scopus, and CINAHL. The World Health Organization's ethical framework proposed for the entire population during the pandemic was applied to thematically delineate findings under equality, best outcomes (utility), prioritizing the worst off, and prioritizing those tasked with helping others. The findings demarcate ethical concerns about the validity of drug and vaccine trials in developing and developed countries, hints of unjust healthcare organizational policies, lack of equal allocation of pertinent resources, miscalculated allocation of resources to essential workers and stratified populations.Copyright: © Pakistan Journal of Medical Sciences.

6 keywords...

hide…